Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001181431-04-009900
Filing Date
2004-02-17
Accepted
2004-02-17 14:52:20
Documents
1
Period of Report
2003-10-29

Document Format Files

Seq Description Document Type Size
1 rrd31847.html 4/A  
1 rrd31847.xml 4/A 3906
  Complete submission text file 0001181431-04-009900.txt   5697
Mailing Address
Business Address 321 ARSENAL STREET WATERTOWN MA 02472 6176737800
OXIGENE INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address DEUTSCHE BANK ASSET MANAGEMENT 6TH FLOOR 280 PARK AVENUE NEW YORK NY 10017
Business Address DEUTSCHE BANK ASSET MANAGEMENT 6TH FLOOR 280 PARK AVENUE NEW YORK NY 10017 2124541219
SHIEBLER WILLIAM N (Reporting) CIK: 0001221432 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-21990 | Film No.: 04607614